Explore
Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier
Joshua D. Nosanchuk and Carlos P. Taborda
2017
0 Ungluers have
Faved this Work
Login to Fave
Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from certain compromised hosts. Additionally, invasive fungal diseases continue to have unacceptably high mortality rates. A growing body of work has focused on the utility of vaccines and/or immunotherapy as a powerful tool in combating mycoses, either for the active treatment, as an adjuvant, or in the prevention of specific fungal pathogens. Also, it is growing the interest over new drugs development as second choice for treatment when traditional chemotherapy fail. This Research Topic will detail the exciting progress in developing vaccines, immunotherapy and new drugs for fungi.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 314 times via unglue.it ebook links.
- 57 - mobi (CC BY) at Unglue.it.
- 125 - epub (CC BY) at Unglue.it.
- 132 - pdf (CC BY) at Unglue.it.
Keywords
- antibody
- antifugal drugs
- cell biology
- Fungi
- humanized antibody
- Immunotherapy
- mycosis
- peptide
- Vaccine
- Virulence
Links
DOI: 10.3389/978-2-88945-327-6Editions